newsfilter
← Latest News
ACCESS Newswire·

CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential best-in-class,